These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31938048)

  • 1. PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness.
    Hamyeh M; Bernex F; Larive RM; Naldi A; Urbach S; Simony-Lafontaine J; Puech C; Bakhache W; Solassol J; Coopman PJ; Hendriks WJAJ; Freiss G
    Theranostics; 2020; 10(3):1016-1032. PubMed ID: 31938048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
    Zhu JH; Chen R; Yi W; Cantin GT; Fearns C; Yang Y; Yates JR; Lee JD
    Oncogene; 2008 Apr; 27(18):2525-31. PubMed ID: 17982484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo.
    Ramovs V; Secades P; Song JY; Thijssen B; Kreft M; Sonnenberg A
    Breast Cancer Res; 2019 May; 21(1):63. PubMed ID: 31101121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.
    Scrima M; De Marco C; De Vita F; Fabiani F; Franco R; Pirozzi G; Rocco G; Malanga D; Viglietto G
    Am J Pathol; 2012 Mar; 180(3):1202-1214. PubMed ID: 22245727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells.
    Aptecar L; Puech C; Lopez-Crapez E; Peter M; Coopman P; D'Hondt V; Freiss G
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
    Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
    Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.
    Liu T; Zhang H; Sun L; Zhao D; Liu P; Yan M; Zaidi N; Izadmehr S; Gupta A; Abu-Amer W; Luo M; Yang J; Ou X; Wang Y; Bai X; Wang Y; New MI; Zaidi M; Yuen T; Liu C
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7683-7688. PubMed ID: 28674022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.
    Zhan H; Jiang J; Luo C; Sun Q; Ke A; Sun C; Hu J; Hu Z; Hu B; Zhu K; Fan J; Zhou J; Huang X
    Tumour Biol; 2016 Jul; 37(7):9691-8. PubMed ID: 26801674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.
    He Q; Jing H; Liaw L; Gower L; Vary C; Hua S; Yang X
    Sci Rep; 2016 Mar; 6():23216. PubMed ID: 26976794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research.
    Wang K; Xie S; Ren Y; Xia H; Zhang X; He J
    Oncol Rep; 2012 Jun; 27(6):1981-9. PubMed ID: 22446691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
    Liu J; Chen X; Ward T; Pegram M; Shen K
    Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
    Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
    Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [
    Chan C; Fonge H; Lam K; Reilly RM
    Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway.
    Hoover AC; Strand GL; Nowicki PN; Anderson ME; Vermeer PD; Klingelhutz AJ; Bossler AD; Pottala JV; Hendriks WJ; Lee JH
    Oncogene; 2009 Nov; 28(45):3960-70. PubMed ID: 19734941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinoma.
    Hu Z; Fang H; Wang X; Chen D; Chen Z; Wang S
    Oncol Rep; 2014 Jul; 32(1):205-12. PubMed ID: 24858400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo.
    Zhang J; Li K; Zhang Y; Lu R; Wu S; Tang J; Xia Y; Sun J
    BMC Cancer; 2019 Jun; 19(1):555. PubMed ID: 31182056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].
    Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.